Sentiment Analysis of the earnings transcript to help figure out if there are any bullish or bearish sentiments that could be gathered from it. We're doing ML and AI based analysis on the earnings call to get some more insights.
Please consider a small donation if you think this website provides you with relevant information
| Statement |
|---|
| We are proud of the results we achieved through relentless focus on meaningful applications of 3D printing |
| We are proud of the thousands and thousands of products we have improved through prototyping |
| We are confident that under her leadership, Materialise will continue its track as a built-to-last company |
| We strongly believe that Brigitte and her executive committee will continue to bring innovative solutions to the Materialise customer base |
| We are convinced that the new but highly experienced executive committee will be well placed to deliver value to the shareholders |
| And we are proud about the thousands and thousands of patients we made healthier with patient-specific instruments and implants |
| The verticals of Materialise, the medical segment in particular, demonstrate our good digital backbone from patient data over surgical planning to automate the design using advanced IT tools in a global context enables to scale AM economically |
| Adjusted EBITDA for the third quarter increased significantly from €0.2 million last year to €1.8 million this year, representing an improved adjusted EBITDA margin of 16.5% |
| You will see that the Materialise Medical continued growing at a solid double-digit pace of more than 13%, with revenue increase coming both from medical software and from medical device solutions |
| Its applications we thought could contribute to a better and healthier world |
| Adjusted EBITDA amounted to €7.1 million compared to €4.8 million last year, resulting in improved adjusted EBITDA margin of 29.4% |
| So personalization is a fundamental tendency in the medical device sector, in which, as you know, we are well pleased with our complete platform of research tools and later on solutions to support the rollout of the personalized approaches in different surgical disciplines |
| Our medical segment, on the other hand, continued its double-digit revenue growth and grew by 13% |
| It helped a robust user experience ushering [indiscernible] fast forward today, and we see [indiscernible] |
| Net financial income for Q3 was positive with €1.3 million, including currency exchange gains of €4.6 million in addition to growing interest income on our cash deposits, which are more than offsetting the interest cost on outstanding loans |
| Despite the more moderate revenue growth this quarter, we were able to significantly improve our profitability through a continued focus on scaling effects and cost control |
| I have full confidence that in this new constellation, Materialise remains in good, safe and innovative hands |
| Cash flow from operating activities for the third quarter of 2023 increased to €8.1 million compared to €3.8 million last year, mainly driven by a strong EBITDA |
| Software revenue grew by 10%, while our medical device business expanded by an aggregate of 15% |
| Thanks to many people around us, all over the world that started sharing the dream, we were able to build a sustainable organization called Materialise |
| At the end of the third quarter of 2023, our balance sheet remains strong |
| Well, guys, congrats really solid results given what we've seen from some of the other companies in the space here |
| The consolidated adjusted EBITDA grew to €7.9 million, representing an adjusted EBITDA margin of 13.1% compared to €5.1 million of adjusted EBITDA for the same period last year, which is an increase of almost 55% |
| Cash reserves amounted to €134 million, while our borrowings position further decreased to €66.2 million, resulting in an improved net cash position of €67.7 million |
| As a result of these factors, the group's operating result was positive at €2.3 million compared to a negative €0.3 million last year |
| Is there that the scalability of 3D printing currently hits another roadblock? In the '90s and the early 2000s, the remarkable partnership between Intel and Microsoft, often referred to as Wintel, played a pivotal role in propelling the computer industry to new heights |
| It's been fantastic working with you guys |
| Over her tenure at the helm of Materialise Medical, she has grown this segment to become the most profitable of all the company segments today |
| stock market and that we have been able to fulfill all the legal requirements consistently |
| And we believe that we will be able to continue closing interesting contracts with medical device manufacturers |
| Statement |
|---|
| As mentioned earlier, revenue decreased 3.8% to €25.1 million, mainly due to a general slowdown in the prototyping markets |
| More challenging market conditions impacted the segment's revenue and gross margin |
| Revenue from nonrecurring sales, on the other hand, decreased 18%, reflecting our continued transition to a recurring business model |
| Troy, we did see our deferred revenue going down in the third quarter, also in the second quarter |
| Adjusted EBITDA for the quarter dropped to €1.1 million, representing an EBITDA margin of 4.3% |
| We are confronted with the situation that the cloud environment in a business-to-business context is actually a more difficult sale than just the, yes, Wintel based, as I said, software programs that run on a laptop because those cloud environments are so different |
| It's not dramatic, but at the same time, it is a little -- going a little bit slower than we expected in the beginning of the year |
| And that's where we are confronted with some delays and some issues in order to roll out more platforms |
| But what is even more important is that companies are doubting what choices they have to make |
| And as such, this complexity may hinder growth of the 3D printing industry where interoperability and compatibility are paramount |
| If you remember, we were over performing |
| Over the past summer months, less favorable market conditions mainly impacted our manufacturing segment, which decreased by 4%, while our software segment remained stable |
| At the same time, the medical device industry is also a little bit affected by the current economic situation and it being careful in its investments, and that weighs a little bit on the growth of our software activities in medical |
| So if you look -- if you compare the current number to beginning of the year, there is indeed a decline |
| In the context of 3D printing and inherently digital technology, this complexity can be particularly problematic |
| And this in spite of the more challenging macroeconomic conditions that we are in |
| And in an economic environment that is not that favorable, doubt is a reason to postpone |
| For many years, the necessity of 3D printing as a manufacturing technology was questioned by money |
| Can you just touch on deferred revs? You guys maxed out here at about €43 million, and we've had a couple of quarters sequentially that it's declined |
| And as a consequence, the advent of distributed manufacturing is delayed |
Please consider a small donation if you think this website provides you with relevant information